Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We are delighted to announce that David Beeson, Professor in Molecular Neurosciences, and Robert MacLaren, Professor of Ophthalmology, have been elected Fellows of the Academy of Medical Sciences.

Robert MacLaren and David Beeson
Robert MacLaren and David Beeson

Professor Beeson has made an exceptional contribution to the study of neuromuscular disorders where the communication between nerve cells and muscle is impaired. His most recent research has focused on translating molecular knowledge of neuromuscular synapse biology into treatment for inherited (congenital) myasthenic syndromes (CMS). Recent work with patients has led to prospective clinical studies showing the dramatic beneficial effects of β2-adrenergic receptor in treating many forms of CMS.

Professor MacLaren  pioneers new treatments for blindness, particularly in patients with incurable retinal diseases, using stem cell-based approaches, gene therapy or electronic retinas. His laboratory is also developing new techniques for cataract and retinal surgery. Together with the University of Oxford in 2014 he co-founded Nightstar, a biotechnology company based at the Wellcome Trust in London, to develop gene therapy treatments for patients with retinal diseases.

Fellowship of the Academy is based on exceptional contributions to the medical sciences, either in the form of original discovery or of sustained contributions to scholarship. Fellows are drawn primarily from biomedical science and academic medicine, but also from veterinary science, dentistry, laboratory science, medical and nursing care and other professions allied to medical science.

Similar stories

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

New study on link between autoimmunity and pain

Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.